Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tgm6em1/Cya
Common Name:
Tgm6-KO
Product ID:
S-KO-07319
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tgm6-KO
Strain ID
KOCMP-241636-Tgm6-B6J-VA
Gene Name
Tgm6
Product ID
S-KO-07319
Gene Alias
TGM3L; TGY
Background
C57BL/6JCya
NCBI ID
241636
Modification
Conventional knockout
Chromosome
2
Phenotype
MGI:3044321
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tgm6em1/Cya mice (Catalog S-KO-07319) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028888
NCBI RefSeq
NM_177726
Target Region
Exon 2~7
Size of Effective Region
~6.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
TGM6 encodes transglutaminase 6, which catalyzes the covalent crosslinking of proteins via transamination reactions [1]. It has also been identified as a natural antagonist of mammalian TGF-β signaling produced by the murine helminth parasite Heligmosomoides polygyrus, mimicking TGF-β binding to TGFBR2 in fibroblasts [3,5].

TGM6 variants have been associated with spinocerebellar ataxia type 35, but there are doubts about its role as a specific causative gene [4,6]. In Parkinson's disease, 12 low-frequency TGM6 variants were found among 308 patients. Mutant TGM6 plasmids showed lower transglutaminase activity than wild-type, and the protective effects of wild-type TGM6 on cells, such as reducing α-synuclein and enhancing autophagy, were weakened in cells transfected with mutant plasmids [1]. A study questioned the pathogenicity of the TGM6 p.L517W variant in spinocerebellar ataxia 35 as it did not segregate with the phenotype [2]. Genetic analysis also indicated that TGM6 might not be a specific causative gene for spinocerebellar ataxia, as the allele frequencies of its variants did not differ among spinocerebellar ataxia patients and controls, and reported pathogenic variants were found in patients with various neurologic diseases or normal controls [4].

In conclusion, TGM6 has functions in protein cross-linking and modulating TGF-β signaling. Its role in spinocerebellar ataxia type 35 is uncertain, while in Parkinson's disease, TGM6 variants may be related to the disease with potential impacts on cellular protective mechanisms. Further research is needed to clarify its exact functions and roles in these neurological conditions.

References:

1. Chen, Kui, Lu, You, Peng, Fang, Tan, Yan, Zhao, Yan-Xin. . TGM6 variants in Parkinson's disease: clinical findings and functional evidence. In Journal of integrative neuroscience, 19, 51-64. doi:10.31083/j.jin.2020.01.1203. https://pubmed.ncbi.nlm.nih.gov/32259886/

2. Chen, Yanxing, Wu, Dengchang, Luo, Benyan, Zhao, Guohua, Wang, Kang. 2020. TGM6 L517W is not a pathogenic variant for spinocerebellar ataxia type 35. In Neurology. Genetics, 6, e424. doi:10.1212/NXG.0000000000000424. https://pubmed.ncbi.nlm.nih.gov/32426513/

3. White, Stephen E, Schwartze, Tristin A, Mukundan, Ananya, Maizels, Rick M, Hinck, Andrew P. 2023. TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.12.22.573140. https://pubmed.ncbi.nlm.nih.gov/38187573/

4. Cheng, Hao-Ling, Dong, Hai-Lin, Liu, De-Shan, Dong, Yi, Wu, Zhi-Ying. 2021. TGM6 might not be a specific causative gene for spinocerebellar ataxia resulting from genetic analysis and functional study. In Gene, 779, 145495. doi:10.1016/j.gene.2021.145495. https://pubmed.ncbi.nlm.nih.gov/33588035/

5. White, Stephen E, Schwartze, Tristin A, Mukundan, Ananya, Maizels, Rick M, Hinck, Andrew P. 2025. TGM6 is a helminth secretory product that mimics TGF-β binding to TGFBR2 to antagonize signaling in fibroblasts. In Nature communications, 16, 1847. doi:10.1038/s41467-025-56954-z. https://pubmed.ncbi.nlm.nih.gov/39984487/

6. Fung, Jasmine L F, Tsang, Mandy H Y, Leung, Gordon K C, Yu, Mullin H C, Chung, Brian H Y. 2019. A significant inflation in TGM6 genetic risk casts doubt in its causation in spinocerebellar ataxia type 35. In Parkinsonism & related disorders, 63, 42-45. doi:10.1016/j.parkreldis.2019.01.013. https://pubmed.ncbi.nlm.nih.gov/30670339/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest